Alentis Therapeutics Revenue
Pharmaceutical Manufacturing • 
Allschwil, Basel-Country, Switzerland • 51-100 Employees
Alentis Therapeutics revenue & valuation
| Annual revenue | $1,000,000 |
| Revenue per employee | $15,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $3,200,000 |
| Total funding | $181,400,000 |
Key Contacts at Alentis Therapeutics
Roberto Iacone
Chief Executive Officer
Silke Appel-Dingemanse
Senior Director Business Development
Thomas Baumert
Founder
Vincent Anquetil
Director Translational Data Science
Corentin Herbert
Director, Translational Research
Aneta Łukaszuk
Global Project Director
Company overview
| Headquarters | Hegenheimermattweg 167a, Allschwil, Basel-Country 4123, CH |
| Website | |
| NAICS | 3254 |
| SIC | 873 |
| Keywords | Cancer, Drug Discovery, Oncology, Nephrology, Rare Diseases, Drug Development, Pulmonology, Hepatology, Fibrosis, ADC, Anca-Associated Vasculitis, Antibody-Drug Conjugates, Liver Fibrosis, Lung Fibrosis, Idiopathic Pulmonary Fibrosis, Ale.F02, Claudin, Cldn1, Claudin-1, Kidney Fibrosis, Hnscc, Ale.P02, Ale.P03, Lixudebart |
| Founded | 2019 |
| Employees | 51-100 |
| Socials |
Alentis Therapeutics Email Formats
Alentis Therapeutics uses 3 email formats. The most common is {first initial}.{last name} (e.g., j.doe@alentis.ch), used 64.7% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@alentis.ch | 66.7% |
{first name}.{last name} | john.doe@alentis.ch | 33.3% |
About Alentis Therapeutics
Alentis Therapeutics is a clinical-stage biotechnology company pioneering first-in-class antibody-drug conjugates (ADCs) and antibodies targeting Claudin-1 (CLDN1) for oncology and multi-organ fibrosis. CLDN1 is a previously unexploited target that plays a key role in the pathology of cancer and fibrotic disease. Alentis is the leading company pioneering CLDN1 ADCs and antibodies to modify and reverse the course of select diseases. Alentis was founded based on ground-breaking research in the laboratory of Prof. Thomas Baumert, MD at the University of Strasbourg and the French National Institute of Health and Medical Research (Inserm). Alentis is headquartered at the pharma-biotech hub in Basel, Switzerland. Visit www.alentis.ch
Employees by Management Level
Total employees: 51-100
Seniority
Employees
Employees by Department
Alentis Therapeutics has 35 employees across 10 departments.
Departments
Number of employees
Funding Data
Explore Alentis Therapeutics's funding history, including investment rounds, total capital raised, and key backers.
Alentis Therapeutics Tech Stack
Discover the technologies and tools that power Alentis Therapeutics's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Analytics
JavaScript libraries
Page builders
JavaScript libraries
JavaScript libraries
Web servers
Miscellaneous
JavaScript libraries
Programming languages
Blogs
Australia
United States
Canada
United Kingdom
GermanyFrequently asked questions
4.8
40,000 users
